![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Department of Drug Metabolism, Merck Research Laboratories, Rahway, New Jersey
(Received December 10, 2002; accepted March 12, 2003)
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResults and DiscussionReferences |
|---|
80 and 50%, respectively. In addition, PH (75 mg/kg/day) elicited
statistically significant changes in renal gene expression of CYP3A1,
UGT1A6, QR, and Mrp3, but the magnitude of renal
Mrp3 induction was less than 2-fold over control. Although PH is
known to modulate hepatic glucuronidation in vivo, these data indicated that
PH induced mRNA levels of the efflux transporter, Mrp3, which may
also affect the disposition of xenobiotics.
;
Hirohashi et al., 1999;
Borst et al., 2000). Notably,
induction of hepatic rat Mrp3 and another transporter, Oatp2, by drugs like
phenobarbital was implicated in the altered disposition of acetaminophen and
the enhanced uptake of digoxin in rats
(Rausch-Derra et al., 2001;
Xiong et al., 2002a). Mrp3
induction has been shown also with oltipraz
(Cherrington et al., 2002), a
dithiolthione phase II enzyme inducer being investigated as a chemoprotectant
against aflatoxin carcinogenicity and hepatotoxicity
(Kwak et al., 2001a). Oltipraz
and other selective phase II inducers, such as 1,7-phenanthroline (PH), offer
a new mechanism of protection against carcinogenic and hepatotoxic compounds
by inducing the enzymes involved in their metabolism [glutathione
S-transferase (GST) and UDP-glucuronosyltransferase (UGT)], without
increasing cytochrome P450-mediated bioactivation
(Franklin and Moody, 1992;
Franklin et al., 1993;
Buetler et al., 1995;
Vargas et al., 1998;
Dong et al., 1999;
Lamb and Franklin, 2000).
Additionally, selective phase II inducers can be used to modulate in vivo
exposure to acyl glucuronides. In this regard, a significant increase in the
glucuronidation of benoxaprofen, a nonsteroidal anti-inflammatory drug, was
observed when rats were treated with PH at 75 mg/kg/day for 3 days, resulting
in a 2-fold increase in the biliary excretion of the acyl glucuronide, and an
8-fold increase in the peak plasma concentration (Cmax)
and area under the curve values of the acyl glucuronide
(Dong et al., 1999).
In the present study, we report that PH significantly induced not only mRNA levels of hepatic phase II enzymes, but also mRNA levels of Mrp3, which is likely to contribute to the altered metabolism and disposition of xenobiotics and their metabolites in PH-treated rats.
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResults and DiscussionReferences |
|---|
In Vivo Animal Studies. All studies were reviewed and approved by the Merck Research Laboratories Institutional Animal Care and Use Committee. Male Sprague-Dawley rats were obtained from Charles River Laboratories Inc. (Wilmington, MA). After an overnight fast, five male Sprague-Dawley rats were dosed orally with PH at 150 mg/kg once daily for 3 days, and four male Sprague-Dawley rats were dosed with vehicle (0.1 M citric acid in 0.5% methylcellulose) in the same manner. Livers were removed from treated and vehicle control rats at 24 h after the last dose and stored at -70°C for quantitation of mRNA. In a separate experiment, three rats were dosed with PH at 75 mg/kg/day for 3 days, and an additional three rats were dosed with vehicle in the same manner. At 24 h after the last dose, the livers and kidneys were removed and stored at -70°C for mRNA quantification.
Development of Specific Primers and Probes for Quantitative Real-Time Polymerase Chain Reaction. Coding sequences for the genes listed in Table 1 were accessed from GenBank. Specific target regions within the coding sequences were determined through nucleotide sequence alignment comparisons of targets within multiple member gene families (e.g., Oatp2 with Oatps, Mrp2 with Mrps, CYP2C11 with CYP2C12, etc.). Primers and probes were designed to the selected target using Applied Biosystems Inc. (Foster City, CA) Primer Express software (v.2.0). All primers and probes were submitted to the National Center for Biotechnological Information for nucleotide comparison using the basic logarithmic alignment search tool (BLASTn) search for short, nearly exact sequences to ensure specificity. Primers and probes were synthesized by QIAGEN Operon (Alameda, CA), where primers were 5'- and 3'-labeled with the 6-carboxyfluorescein and 6-carboxytetram-ethylrhodamine reporter dyes, respectively. The rodent glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primer/probe set was purchased from Applied Biosystems Inc. and used per manufacturer's instructions. Each RNA sample was reverse-transcribed before analysis of different gene expression by PCR. Real-time quantitative PCR was performed using an ABI PRISM 7700 Sequence Detector instrument and Sequence Detector v.1.7 software (PerkinElmer Instruments, Skelton, CT).
|
mRNA Isolation and Quantitative Real-Time Polymerase Chain Reaction. Total RNA from rat tissues was isolated using the SV Total RNA Isolation System (Promega, Madison, WI) according to the manufacturer's instructions. Samples were quantitated by spectrophotometry and diluted to a concentration of 15 ng/µl. Aliquots (500 ng) of RNA were analyzed by agarose/formaldehyde gel electrophoresis to check RNA integrity. Samples were then assayed in triplicate 25-µl reactions using 25 ng of RNA per reaction. Gene-specific primers were used at 7.5 pmol per reaction, and the gene-specific probes were used at 5 pmol per reaction. GAPDH was used to normalize gene expression in all samples since it is a highly expressed gene in rat liver and did not change in response to PH treatment [cycle threshold (Ct), control, 21.8 ± 0.2; PH, 22 ± 0.3]. Fold induction values were calculated by subtracting the mean difference of gene and GAPDH Ct number for each treatment group from the mean difference of gene and GAPDH Ct number for the vehicle group and raising this difference to the power of 2.
Statistical analyses were performed using a two-tailed Student's t
test at 
= 0.01 level of significance.
|
Results and Discussion |
|---|
|
TopAbstractMaterials and MethodsResults and DiscussionReferences |
|---|
; Lamb and
Franklin, 2000), significant increases in the amount of mRNA for
UGT1A6 (20-fold) and, to a lesser extent, UGT2B1 (4-fold)
and QR (5-fold) were detected in rat liver in response to PH
treatment of 150 mg/kg/day (Fig.
1). The mRNA levels of UGT1A1 were not affected
substantially (<2-fold) by this treatment. Similar increases in
UGT1A6 (17-fold), UGT2B1 (3-fold), GST (6-fold),
and QR (11-fold) mRNA were observed in liver after PH treatment of
rats at 75 mg/kg/day for 3 days (Table
2). These results were similar to those reported by Vargas et al.
(1998). The observed lack of
dose proportionality in the increase of the mRNA of these enzymes between 75
and 150 mg/kg of PH needs further investigation to establish the
time-dependence of the induction.
|
|
The transcription factor Nrf2 has been shown to be important for
the induction of phase II enzymes. Induction of QR and
UGT1A6 by oltipraz was observed in the wild-type, but not
nrf2-deficient mice, which suggested that Nrf2 plays a major
role in the regulation of these genes
(Kwak et al., 2001b). Given
that PH causes induction of a battery of genes similar to that of oltipraz,
further studies are needed to elucidate the role of Nrf2, if any, in
the inductive effects of PH.
PH caused a 3- to 4-fold induction of CYP3A1 gene expression in
both liver and kidney; however, this is considered minor in comparison to the
induction of CYP3A1 gene expression by pregnane X receptor agonists
(30-fold) (Hartley and Klaassen,
2000) and may not be associated with increased protein levels
(Dong et al., 1999).
Significant decreases in the mRNA levels of CYP2C11 (17% of control)
and Oatp2 (50% of control) were observed by PH treatment at 150
mg/kg/day. Down-regulation of CYP2C11 and Oatp2 by some aryl
hydrocarbon receptor agonists, such as 3-methylcholanthrene, has been reported
previously (Lee and Riddick,
2000; Rausch-Derra et al.,
2001; Guo et al.,
2002). However, PH does not induce CYP1A2 activity
(Dong et al., 1999), suggesting
that aryl hydrocarbon receptor may not be involved in the PH down-regulation
of CYP2C11 and Oatp2.
In addition to the increases in QR and UGT mRNA levels,
which are consistent with the previous report
(Vargas et al., 1998), we also
demonstrated that PH markedly increased hepatic Mrp3 mRNA levels
(35-fold at 150 mg/kg and 99-fold at 75 mg/kg), but Mrp2 levels
remained unaffected. Mrp3 is located on the basolateral membrane of polarized
cells, and it plays a role in the hepatic elimination by transporting organic
anions from liver to blood, which could lead to increased levels of
xenobiotics and their metabolites in plasma and possibly an increase in
urinary excretion (Konig et al.,
1999; Kool et al.,
1999). In normal rat liver, constitutive expression of
Mrp3 mRNA is very low; however, the inducible nature of Mrp3
is well documented (Ogawa et al.,
2000; Cherrington et al.,
2002). Mrp3 has been shown to be induced by activators of
the constitutive androstane receptor and an antioxidant/electrophile
responsive element (Cherrington et al.,
2002). However, a recent report by Xiong et al.
(2002b) suggests that
Mrp3 regulation occurs independent of constitutive androstane
receptor.
In contrast to the robust increase in gene expression levels for
UGT1A6 and Mrp3 in liver of PH-treated rats, there were much
smaller changes in these genes in kidney by PH treatment at 75 mg/kg for 3
days (Table 2). The lack of
evidence for a robust renal induction of xenobiotic transporters in rats
treated with known hepatic enzyme inducers has been reported previously
(Brady et al., 2002;
Cherrington et al., 2002). In
addition, previous studies have shown minimal inductive effects on
drug-metabolizing genes by PH in the small intestine
(Vargas et al., 1998).
Thus, PH is a pleiotropic inducer of genes responsible for drug metabolism
and transport. These results indicate that in vivo data from PH-induced rats
should be interpreted with caution, since up-regulation of Mrp3 gene
expression may result in increased efflux of glucuronides and other
xenobiotics from liver into the plasma compartment
(Gregus et al., 1990;
Xiong et al., 2002a). Further
studies are needed to investigate the mechanism by which PH induces
Mrp3 and phase II enzymes, and to determine whether these changes in
mRNA levels will correlate with protein levels and/or activity.
|
Footnotes |
|---|
Address correspondence to: Sui Wang, Department of Drug Metabolism, Merck Research Laboratories, P.O. Box 2000, RY80L-109, Rahway, NJ 07065. E-mail: sui_wang{at}merck.com
|
References |
|---|
|
TopAbstractMaterials and MethodsResults and DiscussionReferences |
|---|
This article has been cited by other articles:
|
|
 |
|
  B. N. M. Zordoky, M. E. Aboutabl, and A. O. S. El-Kadi Modulation of Cytochrome P450 Gene Expression and Arachidonic Acid Metabolism during Isoproterenol-Induced Cardiac Hypertrophy in Rats Drug Metab. Dispos., November 1, 2008; 36(11): 2277 - 2286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Osabe, J. Sugatani, T. Fukuyama, S.-i. Ikushiro, A. Ikari, and M. Miwa Expression of Hepatic UDP-Glucuronosyltransferase 1A1 and 1A6 Correlated with Increased Expression of the Nuclear Constitutive Androstane Receptor and Peroxisome Proliferator-Activated Receptor {alpha} in Male Rats Fed a High-Fat and High-Sucrose Diet Drug Metab. Dispos., February 1, 2008; 36(2): 294 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Johnson, P. Zhang, J. D. Schuetz, and K. L. R. Brouwer CHARACTERIZATION OF TRANSPORT PROTEIN EXPRESSION IN MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) 2-DEFICIENT RATS Drug Metab. Dispos., April 1, 2006; 34(4): 556 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Kim, S. Wang, Z. Shen, C. J. Kochansky, J. R. Strauss, R. B. Franklin, and S. H. Vincent DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS Drug Metab. Dispos., September 1, 2004; 32(9): 909 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Hartley, X. Dai, Y. D. He, E. J. Carlini, B. Wang, S.-e. W. Huskey, R. G. Ulrich, T. H. Rushmore, R. Evers, and D. C. Evans Activators of the Rat Pregnane X Receptor Differentially Modulate Hepatic and Intestinal Gene Expression Mol. Pharmacol., May 1, 2004; 65(5): 1159 - 1171. [Abstract] [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|
 |
 |
 |
